Evaluation of the Level of Satisfaction of Patients with the Use of a Newly Marketed Vaginal Gel (Satisvag Survey)
Received Date: Mar 15, 2018 / Accepted Date: Mar 24, 2018 / Published Date: Mar 28, 2018
Objective: To evaluate the general level of satisfaction of the patients in relation to the use of Palomacare®, a multi-ingredient, non-hormonal vaginal gel with moisturizing and restorative properties indicated for the improvement of symptoms and signs that make up the genitourinary syndrome, after its recent commercialization.
Methods: The satisvag survey was addressed during the first quarter of 2016 to Spanish Gynaecologists who were visiting women that already were using Palomacare®. At the end, collected data were analyzed.
Results: A total of 62 doctors participated in the survey, ~ 90% of them had ≥ 5 patients using Palomacare®. 98% of survey respondents indicated the overall satisfaction with Palomacare® in their patients is good or excellent. On the other hand, 84% of them stated that patients considered the product better or much better than previous treatments, respectively.
Conclusion: After analyzing the data we assured that Palomacare® is a well-tolerated product with a comfortable application. Its specific features make the product use highly satisfactory and perceived as better than other previous treatments.
For any product that is administered vaginally, both the comfort of application and the sensations of the patient are key factors to determine overall satisfaction. This has a direct impact on the adherence and, ultimately, the effectiveness of the prescribed treatment. Quickly understanding the advantages and disadvantages of a newly marketed product, could be useful to improve prescription habits and patient response [1-5].
Palomacare® is a multi-ingredient including Niosome and Phytosome particles, which contains Hyaluronic Acid and natural ingredients. This medical device marketed in Spain since July 2015 [6-9]. Vaginally applied in the form of a gel with moisturizing and restorative properties of the vaginal mucosa, it is indicated for improvement of symptoms and signs that make up the genitourinary syndrome.
The Satisvag survey was conducted during the first quarter of 2016. A questionnaire of eight questions was performed related to the use of Palomacare® in clinical practice. The survey was targeted to Spanish gynecologists already prescribing Palomacare® to their patients and followed a homogeneous distribution across the country. Data quality was ensured through double-entry Microsoft Excel®.
A total of 62 doctors participated in the survey, having the ~ 90% of them ≥ 5 patients using Palomacare®. 98% of survey respondents indicated the overall satisfaction with Palomacare® in their patients is good or excellent (Q2). Data concerning to both general comfort and general comparison to other products (Q3 and Q5) are shown in Figure 1.
95% indicated that absorption, understood as the absence of product loss, is good or excellent (Q4). The main advantages of Palomacare® highlighted by users, especially compared to previous products are shown in Figure 2 (Q6). Nearly 90% of doctors said that no patient reported any adverse effect (Q7). Stinging/burning was indicated as the most common adverse effect observed.
Palomacare® is a well-tolerated product with a comfortable application. Its specific features make the product use highly satisfactory and perceived as better than other previous treatments.
- Palacios S, Losa F, Combalia J, Emsellem C, Gaslain Y, et al. (2018) Evaluation of the Benefits of a Newly Marketed Vaginal Gel (Palomacare®) on Vaginal Health of Peri and Postmenopausal Women (Atrovag Survey). EC Gynaecology 7: 104-106.
- Karaosmanuglu O (2011) Hyaluronic acid in the treatment of postmenopausal women with atrophic vaginitis. Int J Gynaecol Obstet 113: 156-157.
- Brochure Nio-Glucan. Naturalis life technologies (Italy).
- Lu L (2004) Asiatic acid induction for cell-cycle progression proliferation and collagen synthesis in human dermal fibroblasts. Int J Dermatol 43: 801-807.
- Lee JH, Kim HL, Lee MH, You KE, Kwon BJ, et al. (2012) Asiaticoside enhances normal human skin cell migration, attachment, and growth in vitro wound healing model. Phytomedicine.
- Hashim P (2014) The effect of Centella Asiatica, vitamins, glycolic acid and their mixtures preparation in stimulating collagen and fibronectin synthesis in cultured human skin fibroblast. Pak J Pharm Sci 27: 233-237.
- Brochure Bioecolia (2013) Via Farma. Iparanga Brazil.
- Molazem Z, Mohseni F, Younesi M, Keshavarzi S (2014) Aloe vera gel, and cesarean wound healing: a randomized controlled clinical trial. Global J Health Sci 31: 203-209.
- Khan AW, Kotta S, Ansari SH, Sharma RK, Kumar A, et al. (2013) Formulation development, optimization and evaluation of aloe vera gel for wound healing. Pharmacogn Mag 9 (Suppl 1): S6-S10.
- Chu K, Ho SS, Chow AH (2002) Coriolus versicolor: a medicinal mushroom with promising immunotherapeutic values. Journal of Clinical Pharmacology 42: 976-984.
- Palacios S, Losa F, Dexeus D, Cortés J (2017) Beneficial effects of a Coriolus versicolor based vaginal gel on cervical epithelization, vaginal microbiota, and vaginal health: a pilot study in asymptomatic women. BMC Women´s Health 17: 21.
Citation: Palacios S, Losa F, Combalia J, Emsellem C, Gaslain Y, et al. (2018) Evaluation of the Level of Satisfaction of Patients with the Use of a Newly Marketed Vaginal Gel (Satisvag Survey). Gynecol Obstet 8: 467. DOI: 10.4172/2161-0932.1000467
Copyright: ©2018 Palacios S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
- Total views: 911
- [From(publication date): 0-2018 - Jan 21, 2019]
- Breakdown by view type
- HTML page views: 869
- PDF downloads: 42